Nikhil Chopra to now spearhead JB Chemicals, appointed as Director, CEO

Published On 2020-10-06 07:19 GMT   |   Update On 2022-12-07 06:44 GMT

New Delhi: Former Cipla India Business Head, Nikhil Chopra, will now lead J B Chemicals & Pharmaceuticals as its's board has appointed him as Whole-time Director and Chief Executive Officer of the company."The board of directors of the company has appointed Chopra as Whole-time Director and CEO for a period of five years," J B Chemicals & Pharmaceuticals said in a filing to the...

Login or Register to read the full article

New Delhi: Former Cipla India Business Head, Nikhil Chopra, will now lead J B Chemicals & Pharmaceuticals as its's board has appointed him as Whole-time Director and Chief Executive Officer of the company.

"The board of directors of the company has appointed Chopra as Whole-time Director and CEO for a period of five years," J B Chemicals & Pharmaceuticals said in a filing to the BSE.

Prior to joining the company, Chopra worked as Head-India Business at Cipla Ltd, it added.

With a 24 years stint at Cipla since 1996, Chopra had been instrumental in integrating the generics business, worth around Rs 6000 crore. He had played a key role in Cipla's initiative of "Go Beyond the Pill" through patient awareness and facilitating low-cost diagnostic options in respiratory treatment.

He had played important role in integrating around 20 businesses of the company into 4 major clusters.

Also Read: Mega Exit: Cipla India Top Boss, 2 Senior Executives Step Out After 24 Year Stint

Chopra has over 20 years of experience backed up with a consistent record of sustainable growth and shareholder value creation, the filing said.

He holds M.Sc. in Organic Chemistry from Gujarat University, reports PTI.

Tags:    
Article Source : with agency inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News